Abstract
Background Evidence have shown that the prescribed lockdown and social distancing due to the novel coronavirus disease 2019 (COVID-19) has made accessing essential health care much more difficult in low-and middle-income countries (LMICs). Access to contraception is essential and should not be denied, even in the time of a global crisis because it is associated with health benefits. It is paramount to maintain timely access to contraception without unnecessary barriers. Hence, this study examines the factors contributing to inadequate access to contraception and sources of contraception during the COVID-19 pandemic in South Africa (SA).
Method The first secondary dataset on coronavirus from the National Income Dynamic Study (NIDS) conducted in SA during the coronavirus pandemic was employed in this study. This study involved 6,829 respondents. Data was analysed using chi-square and binary logistic regression analysis.
Results Over one-quarter of South Africans could not access contraception and more than every 7 in 10 South Africans preferred public or government hospital as source of contraception. Female South Africans (OR=0.89 CI:0.7487–1.0719) and those aged 65 years above (OR=0.67 CI:0.4485–0.9988) were 33% and 11% respectively less likely to have access to contraception. The preferred sources of contraception were associated with the selected demographic and economic variables at P<0.05.
Conclusions Findings from the study suggests strategies and interventions that will be tailored towards non-obstruction of contraception access during the on-going COVID-19 or any future pandemic. Moreover, special consideration should be given to certain provinces and those in 3rd quintile of wealth income.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
N/A
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval for NIDS-CRAM was granted by the University of Cape Town (UCT) Commerce Faculty Ethics Committee. In 2017, the NIDS data collectors (Wave 5) conducted a written informed consent process for all participants, and only resumed interviews until this procedure had been completed. NIDS-CRAM 2020 drawn from the same population sample; hence the consent of the participants was re-validated via telephone interview before proceeding with relevant questions
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The National Income Dynamics Study-Coronavirus Rapid Mobile Survey (NIDS-CRAM) repressed dataset can be accessed via the NIDS website (http://www.nids.uct.ac.za). Alternatively, data that includes sensitive information may be obtained via the University of Cape's application process with Dataset (www.datarst.uct.ac.za).
